Genotype-Based Risk and Pharmacogenetic Sampling in Clinical Trials

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.20, Iss.2, 2010-03, pp. : 315-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives

By Fogli Stefano Caraglia Michele

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. : 1095-1108

Informa Healthcare

Access to resources Recommend Favorite

Genotype-based dosing strategy for azathioprine valid in RA, SLE

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Clinical Trials and Evidence-Based Medicine

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 413-420

Bentham Science Publishers

Access to resources Recommend Favorite

A Bootstrap-Based Test for Establishing Noninferiority in Clinical Trials

By Chen Michael

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 357-363

Taylor & Francis Ltd

Access to resources Recommend Favorite